Role of hydroxycarbamide in prevention of complications in patients with sickle cell disease
NM Wiles, J HowardDepartment of Haematology, St Thomas’ Hospital, Westminster, Bridge Road, London, SE1 7EH, UKAbstract: Sickle cell disease (SCD) is a genetically inherited condition caused by a point mutation in the beta globin gene. This results in the production of the abnormal hem...
Main Authors: | NM Wiles, J Howard |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2009-09-01
|
Series: | Therapeutics and Clinical Risk Management |
Online Access: | http://www.dovepress.com/role-of-hydroxycarbamide-in-prevention-of-complications-in-patients-wi-a3561 |
Similar Items
-
The use of hydroxycarbamide in children with sickle cell anemia
by: Hafsat Rufai Ahmad, et al.
Published: (2018-01-01) -
Dermatological Toxicity of Hydroxycarbamide
by: IN Subortseva, et al.
Published: (2018-07-01) -
Hydrophylic interaction chromatography used for separation of hydroxycarbamide and urea
by: A. S. Osipov, et al.
Published: (2018-02-01) -
Quantitative analysis of the erythrocyte membrane proteins in polycythemia vera patients treated with hydroxycarbamide
by: Darshana Kottahachchi, et al.
Published: (2015-06-01) -
Sickle cell disease complications
by: Ersi Voskaridou
Published: (2014-12-01)